Insights

Key Personnel GenSight Biologics recently appointed William Monteith to its Board of Directors, bringing valuable expertise to drive business growth and potential collaborations.

Market Expansion Partnerships with industry regulators like Autorités des Marchés Financiers and high-growth digital companies indicate GenSight Biologics' strategic approach to expand its market presence and explore new revenue streams.

Product Launches The successful manufacturing of two Drug Substance batches of LUMEVOQ demonstrates GenSight Biologics' commitment to bringing innovative therapies to market, presenting opportunities for potential partnerships and sales.

Executive Leadership The appointment of Laurence Rodriguez as Chief Executive Officer signals a new phase of leadership, potentially opening doors for business development initiatives and strategic collaborations.

Research Advancements Scientific updates on LUMEVOQ and the cutting-edge gene therapy approach utilized by GenSight Biologics present a strong value proposition to potential partners and investors seeking innovative solutions in biotechnology research.

GenSight Biologics Tech Stack

GenSight Biologics uses 8 technology products and services including Google Analytics, WordPress Super Cache, WordPress, and more. Explore GenSight Biologics's tech stack below.

  • Google Analytics
    Analytics
  • WordPress Super Cache
    Caching
  • WordPress
    Content Management System
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • OWL Carousel
    Javascript Libraries
  • Google Maps
    Maps
  • PHP
    Programming Languages

Media & News

GenSight Biologics's Email Address Formats

GenSight Biologics uses at least 1 format(s):
GenSight Biologics Email FormatsExamplePercentage
FLast@gensight-biologics.comJDoe@gensight-biologics.com
42%
First.Last@gensight-biologics.comJohn.Doe@gensight-biologics.com
11%
First@gensight-biologics.comJohn@gensight-biologics.com
5%
FLast@gensight-biologics.comJDoe@gensight-biologics.com
42%

Frequently Asked Questions

Where is GenSight Biologics's headquarters located?

Minus sign iconPlus sign icon
GenSight Biologics's main headquarters is located at 74 rue du Faubourg Saint Antoine Paris, Ile de France 75012 FR. The company has employees across 2 continents, including EuropeNorth America.

What is GenSight Biologics's phone number?

Minus sign iconPlus sign icon
You can contact GenSight Biologics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is GenSight Biologics's official website and social media links?

Minus sign iconPlus sign icon
GenSight Biologics's official website is gensight-biologics.com and has social profiles on LinkedIn.

How much revenue does GenSight Biologics generate?

Minus sign iconPlus sign icon
As of October 2024, GenSight Biologics's annual revenue reached $7.5M.

What is GenSight Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
GenSight Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does GenSight Biologics have currently?

Minus sign iconPlus sign icon
As of October 2024, GenSight Biologics has approximately 38 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: L. R.Chief Medical Officer: M. T.Chief Technology Officer: S. J.. Explore GenSight Biologics's employee directory with LeadIQ.

What industry does GenSight Biologics belong to?

Minus sign iconPlus sign icon
GenSight Biologics operates in the Biotechnology Research industry.

What technology does GenSight Biologics use?

Minus sign iconPlus sign icon
GenSight Biologics's tech stack includes Google AnalyticsWordPress Super CacheWordPressMySQLFont AwesomeOWL CarouselGoogle MapsPHP.

What is GenSight Biologics's email format?

Minus sign iconPlus sign icon
GenSight Biologics's email format typically follows the pattern of . Find more GenSight Biologics email formats with LeadIQ.

How much funding has GenSight Biologics raised to date?

Minus sign iconPlus sign icon
As of October 2024, GenSight Biologics has raised $10M in funding. The last funding round occurred on May 07, 2024 for $10M.

When was GenSight Biologics founded?

Minus sign iconPlus sign icon
GenSight Biologics was founded in 2013.
GenSight Biologics

GenSight Biologics

Biotechnology ResearchIle de France, France11-50 Employees

GenSight Biologics  is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in teens and young adults. Using its gene therapy-based approach, GenSight Biologics’ product candidates are designed to be administered in a single treatment to each eye by intravitreal injection to offer patients a sustainable functional visual recovery.

Section iconCompany Overview

Headquarters
74 rue du Faubourg Saint Antoine Paris, Ile de France 75012 FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $10M

    GenSight Biologics has raised a total of $10M of funding over 14 rounds. Their latest funding round was raised on May 07, 2024 in the amount of $10M.

  • $10M

    GenSight Biologics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    GenSight Biologics has raised a total of $10M of funding over 14 rounds. Their latest funding round was raised on May 07, 2024 in the amount of $10M.

  • $10M

    GenSight Biologics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.